When Jane Peterson came on as CEO and president of the Keystone Symposia in April of 2014, one of her goals was to expand the organization’s global reach. A 501(c)3 nonprofit organization, the ...

The Endocrine Society, a global organization that promotes endocrinology research and clinical practice, and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science ...

A couple of months ago, Keystone Symposia hosted a community forum on Alzheimer’s disease at Colorado Mountain College in Breckenridge. The speakers were all leading research scientists drawn from the ...

The conference will feature a provocative keynote address by Dr. Peter Hotez, titled "Vaccines and Immunizations in a Time of Global Boiling, Megacities, and Antiscience," addressing the growing ...

SILVERTHORNE, CO - August 11, 2015 - Keystone Symposia on Molecular and Cellular Biology has received a fifth three-year grant from the Bill & Melinda Gates Foundation to help fund conferences in its ...

Keystone Symposia on Molecular and Cellular Biology has received a 3- year grant of $2,599,679 to support an expansion of Keystone Symposia’s Global Health Series. For 35 years, Keystone Symposia has ...

Title: "GEOCM04S1 vaccine candidate maintains potent crossreactivity against original SARSCoV2 B.1 and Omicron subvariant XBB.1.5." When: June 6, 2025 at 7:30 p.m. "These presentations underscore our ...

SILVERTHORNE, CO – July 19, 2012 – Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a fourth grant from the Bill & Melinda Gates Foundation to promote ...

November 6, 2009 - Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a second grant from the Bill & Melinda Gates Foundation to fund conferences on ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Orpheris, a clinical stage neuroscience company leveraging a novel platform technology that enables the selective delivery of therapeutic agents across the blood ...

SAN DIEGO--(BUSINESS WIRE)--Lassen Therapeutics, a biotech company developing breakthrough antibody therapeutics as potential treatments for fibrosis, rare diseases and oncology, today announced plans ...